| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $5,358,537 | -24,118 | -0.43% | $222.18 | 5,553,296 | 28 Dec 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $3,687,680 | -16,750 | -0.3% | $220.16 | 5,536,546 | 29 Dec 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $218.395 to $229.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $217.635 to $221.125. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |